Followers

June 25, 2024

China's Fosun offers to buy out Henlius Biotech, valuing drugmaker at $1.71 bln

"The listing status of Henlius no longer provides meaningful access to capital and imposes additional costs on Henlius," the conglomerate said in a statement.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/iK2EgSX

No comments:

Post a Comment